Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_assertion type Assertion NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_head.
- NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_assertion description "[We used ALK fusion-positive and -negative lung cancer cell lines; crizotinib, PHA-665752, and saracatinib, and stable transfection with shMET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_provenance.
- NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_assertion evidence source_evidence_literature NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_provenance.
- NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_assertion SIO_000772 24490607 NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_provenance.
- NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_assertion wasDerivedFrom befree-2016 NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_provenance.
- NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_assertion wasGeneratedBy ECO_0000203 NP1151557.RAv09SHg9vJPbBInjdFRKhcjB56M4IxXQp2hgUvpYkThA130_provenance.